Cialis Adverse Reactions

Cialis 5 mg: Summary of the safety profile: The most commonly reported adverse reactions in patients taking TADALAFIL for the treatment of erectile function or benign prostatic hyperplasia were headache, dyspepsia, back pain and myalgia, in which the incidences increase with increasing dose of TADALAFIL.
The adverse reactions reported were transient, and generally mild or moderate. Adverse reaction data are limited in patients over 75 years of age.
Tabulated summary of adverse reactions: The table below (table 2) lists the adverse reactions observed from spontaneous reporting and in placebo-controlled clinical trials (comprising a total of 7,116 patients on TADALAFIL and 3,718 patients on placebo) for on-demand and once-a-day treatment of erectile dysfunction and the once-a-day treatment of benign prostatic hyperplasia.
Adverse reactions: Frequency estimate: Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000), Very Rare (<1/10,000) and Not known (events not reported in registration trials cannot be estimated postmarketing spontaneous reports). (See Table 2.)

Click on icon to see table/diagram/image

Description of selected adverse reactions: A slightly higher incidence of ECG abnormalities, primarily sinus bradycardia, has been reported in patients treated with tadalafil once a day as compared with placebo. Most of these ECG abnormalities were not associated with adverse reactions.
Cialis 20 mg: The most commonly reported adverse reactions were headache and dyspepsia. The adverse reactions reported were transient, and generally mild or moderate. Adverse reaction data are limited in patients over 75 years of age.
The table below (table 3) lists the adverse reactions reported during placebo-controlled clinical trials for registration in patients treated with CIALIS. Adverse reactions are also included that have been reported from postmarketing surveillance.
Adverse reactions: Frequency estimate: Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000), Very Rare (<1/10,000) and Not known (events not reported in registration trials cannot be estimated from postmarketing spontaneous reports). (See Table 3.)

Click on icon to see table/diagram/image